This dominant negative disease mechanism has been suggested for some VEGFR3 variants associated with primary lymphedema.26 The variants in this category predominantly associated with LRFH with fetal hydrops, lymphovenous abnormalities, and ASD, some with very mild symptoms (e.g., FH3). This evidence concerns the gene FLT4 and primary lymphedema.